news.volyx.in

Unity plan pricing and packaging updates (blog.unity.com)

501 points by aschearer · 1078 days ago · 526 comments on HN

Article summary

Unity has canceled its Runtime Fee for game customers, effective immediately, after consultation with its community and customers. The company will revert to its existing seat-based subscription model for gaming customers. Unity Personal will remain free, with a revenue and funding ceiling increase from $100,000 to $200,000 USD. The company will modify subscription pricing and qualifying annual revenue thresholds for Unity Pro and Enterprise plans, effective January 1, 2025.

Main themes

  • Unity Runtime Fee
  • game development costs
  • pricing models
  • developer concerns
  • advertising in games
  • game development industry trends

What commenters say

  • The Runtime Fee was seen as a misguided attempt to charge game developers per install, which could be detrimental to their business.
  • Some commenters believe that the fee would only affect successful games and would be a minor cost compared to other expenses.
  • Others argue that the fee would be a significant burden for small developers and could drive them away from using Unity.
  • The pricing model is seen as overly complex and potentially unfair, with some arguing that it could incentivize developers to remove their games from the market.
  • There is disagreement over whether the fee is comparable to app store fees, with some arguing that it is similar and others claiming it is more onerous.
  • Some commenters are concerned that the fee could lead to more ads in games, as developers may be incentivized to use Unity's ad network to reduce their costs.
  • The cancellation of the Runtime Fee is seen as a positive move by Unity, but some commenters are skeptical about the company's motivations and the potential impact on developers.
  • The discussion highlights the challenges of game development and the need for fair and transparent pricing models that support developers rather than hindering them.